Advancing the understanding of autism disease mechanisms through genetics

Nature Medicine

Volumn 22, Issue 4, 2016, Pages 345-361

  De La Torre Ubieta, Luis ^a   Won, Hyejung ^a   Stein, Jason L ^a,b   Geschwind, Daniel H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; ALPHA [AMINO(4 AMINOPHENYLTHIO)METHYLENE] 2 (TRIFLUOROMETHYL)PHENYLACETONITRILE; ARIPIPRAZOLE; BUMETANIDE; CLENBUTEROL; CLIOQUINOL; CLONAZEPAM; FINGOLIMOD; OXYTOCIN; RAPAMYCIN; RISPERIDONE; ROSCOVITINE;

ASTROCYTOSIS; AUTISM; BRAIN CORTEX; BRAIN DEVELOPMENT; CONCEPTUAL FRAMEWORK; COPY NUMBER VARIATION; DSM-5; GENETIC ANALYSIS; GENETIC MODEL; GENETIC TRANSCRIPTION; GENETICS; GLIA CELL; HUMAN; LEARNING DISORDER; MICROGLIA; MOLECULARLY TARGETED THERAPY; NERVE CELL; NERVOUS SYSTEM INFLAMMATION; NEUROBIOLOGY; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE; ANIMAL; AUTISM SPECTRUM DISORDER; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DISEASE MODEL; GENETIC PREDISPOSITION; PATHOLOGY;

ANIMALS; AUTISM SPECTRUM DISORDER; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MOLECULAR TARGETED THERAPY;

EID: 84962890386     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.4071     Document Type: Review

References (300)

1. Altshuler D., Daly M.J., & Lander E.S. Genetic mapping in human disease. Science 322, 881-888 (2008
2. Gilissen C., et al. Genome sequencing identifies major causes of severe intellectual disability. Nature 511, 344-347 (2014
3. Lee H., et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. J. Am. Med. Assoc. 312, 1880-1887 (2014
4. Psychiatric GWAS Consortium Bipolar Disorder Working Group. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat. Genet. 43, 977-983 (2011
5. Lambert J.C., et al. Meta-analysis of 74,046 individuals identifies 11 new suscep-tibility loci for Alzheimers disease. Nat. Genet. 45, 1452-1458 (2013
6. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421-427 (2014
7. Hindorff L.A., et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl. Acad. Sci. USA 106, 9362-9367 (2009
8. Geschwind D.H. Autism: many genes, common pathways Cell 135, 391-395 (2008
9. Geschwind D.H. Genetics of autism spectrum disorders. Trends Cogn. Sci. 15, 409-416 (2011
10. Chen J.A., Peñagarikano O., Belgard T.G., Swarup V., & Geschwind D.H. The emerging picture of autism spectrum disorder: genetics and pathology. Annu. Rev. Pathol. 10, 111-144 (2015
11. Geschwind D.H., & Levitt P. Autism spectrum disorders: developmental disconnec-tion syndromes. Curr. Opin. Neurobiol. 17, 103-111 (2007
12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5 5th edn. (American Psychiatric Association, Arlington, Viginia, USA, 2013
13. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators. Prevalence of autism spectrum disorder among children aged 8 years-Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2010. MMWR Surveill. Summ. 63, 1-21 (2014
14. Werling D.M., & Geschwind D.H. Understanding sex bias in autism spectrum disor-der. Proc. Natl. Acad. Sci. USA 110, 4868-4869 (2013
15. Robinson E.B., Lichtenstein P., Anckarsäter H., Happé F., & Ronald A. Examining and interpreting the female protective effect against autistic behavior. Proc. Natl. Acad. Sci. USA 110, 5258-5262 (2013
16. Geschwind D.H. Advances in autism. Annu. Rev. Med. 60, 367-380 (2009
17. Volkmar F.R., & McPartland J.C. From Kanner to DSM-5: autism as an evolving diagnostic concept. Annu. Rev. Clin. Psychol. 10, 193-212 (2014
18. Geschwind D.H., & State M.W. Gene hunting in autism spectrum disorder: on the path to precision medicine. Lancet Neurol. 14, 1109-1120 (2015
19. Rogers S.J., et al. Autism treatment in the first year of life: a pilot study of infant start, a parent-implemented intervention for symptomatic infants. J. Autism Dev. Disord. 44, 2981-2995 (2014
20. Kasari C., Shire S., Factor R., & McCracken C. Psychosocial treatments for indi-viduals with autism spectrum disorder across the lifespan: new developments and underlying mechanisms. Curr. Psychiatry Rep. 16, 512 (2014
21. Jones W., & Klin A. Attention to eyes is present but in decline in 2-to 6-month-old infants later diagnosed with autism. Nature 504, 427-431 (2013
22. Jeste S.S., Frohlich J., & Loo S.K. Electrophysiological biomarkers of diagnosis and outcome in neurodevelopmental disorders. Curr. Opin. Neurol. 28, 110-116 (2015
23. Zafeiriou D.I., Ververi A., Dafoulis V., Kalyva E., & Vargiami E. Autism spectrum disorders: the quest for genetic syndromes. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 162B, 327-366 (2013
24. Miles J.H. Autism spectrum disorders-a genetics review. Genet. Med. 13, 278-294 (2011
25. Betancur C. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res. 1380, 42-77 (2011
26. Gillberg C., & Coleman M. The Biology of the Autistic Syndromes (Mac Keith Press, London, 1992
27. Folstein S., & Rutter M. Genetic influences and infantile autism. Nature 265, 726-728 (1977
28. Hallmayer J., et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch. Gen. Psychiatry 68, 1095-1102 (2011
29. Sandin S., et al. The familial risk of autism. J. Am. Med. Assoc. 311, 1770-1777 (2014
30. Bailey A., et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol. Med. 25, 63-77 (1995
31. Lichtenstein P., Carlström E., Råstam M., Gillberg C., & Anckarsäter H. The genet-ics of autism spectrum disorders and related neuropsychiatric disorders in childhood. Am. J. Psychiatry 167, 1357-1363 (2010
32. Ronald A., & Hoekstra R.A. Autism spectrum disorders and autistic traits: a decade of new twin studies. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 156B, 255-274 (2011
33. Sebat J., et al. Strong association of de novo copy-number mutations with autism. Science 316, 445-449 (2007
34. Szatmari P., et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat. Genet. 39, 319-328 (2007
35. Marshall C.R., et al. Structural variation of chromosomes in autism spectrum disorder. Am. J. Hum. Genet. 82, 477-488 (2008
36. Bucan M., et al. Genome-wide analyses of exonic copy-number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet. 5, e1000536 (2009
37. Glessner J.T., et al. Autism genome-wide copy-number variation reveals ubiquitin and neuronal genes. Nature 459, 569-573 (2009
38. Itsara A., et al. De novo rates and selection of large copy-number variation. Genome Res. 20, 1469-1481 (2010
39. Pinto D., et al. Functional impact of global, rare copy-number variation in autism spectrum disorders. Nature 466, 368-372 (2010
40. Levy D., et al. Rare de novo and transmitted copy-number variation in autistic spec-trum disorders. Neuron 70, 886-897 (2011
41. Griswold A.J., et al. Evaluation of copy-number variations reveals novel candidate genes in autism spectrum disorder-associated pathways. Hum. Mol. Genet. 21, 3513-3523 (2012
42. Neale B.M., et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485, 242-245 (2012
43. De Rubeis S., et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515, 209-215 (2014
44. Iossifov I., et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature 515, 216-221 (2014
45. Iossifov I., et al. De novo gene disruptions in children on the autistic spectrum. Neuron 74, 285-299 (2012
46. ORoak B.J., et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485, 246-250 (2012
47. Sanders S.J., et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485, 237-241 (2012
48. Gilman S.R., et al. Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 70, 898-907 (2011
49. Sanders S.J., et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 70, 863-885 (2011
50. Gratten J., Visscher P.M., Mowry B.J., & Wray N.R. Interpreting the role of de novo protein-coding mutations in neuropsychiatric disease. Nat. Genet. 45, 234-238 (2013
51. ORoak B.J., et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 338, 1619-1622 (2012
52. Morrow E.M., et al. Identifying autism loci and genes by tracing recent shared ances-try. Science 321, 218-223 (2008
53. Strauss K.A., et al. Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N. Engl. J. Med. 354, 1370-1377 (2006
54. Lim E.T., et al. Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders. Neuron 77, 235-242 (2013
55. Yu T.W., et al. Using whole-exome sequencing to identify inherited causes of autism. Neuron 77, 259-273 (2013
56. Lee S.H., et al. Estimating the proportion of variation in susceptibility to schizophre-nia, captured by common SNPs. Nat. Genet. 44, 247-250 (2012
57. Gaugler T., et al. Most genetic risk for autism resides with common variation. Nat. Genet. 46, 881-885 (2014
58. Bulik-Sullivan B.K., et al. LD score regression distinguishes confounding from poly-genicity in genome-wide association studies. Nat. Genet. 47, 291-295 (2015
59. Wray N.R., & Visscher P.M. Quantitative genetics of disease traits. J. Anim. Breed. Genet. 132, 198-203 (2015
60. Oroak B.J., et al. Exome sequencing in sporadic autism spectrum disorders identi-fies severe de novo mutations. Nat. Genet. 43, 585-589 (2011
61. Schaaf C.P., et al. Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders. Hum. Mol. Genet. 20, 3366-3375 (2011
62. Zhao X., et al. A unified genetic theory for sporadic and inherited autism. Proc. Natl. Acad. Sci. USA 104, 12831-12836 (2007
63. Ronemus M., Iossifov I., Levy D., & Wigler M. The role of de novo mutations in the genetics of autism spectrum disorders. Nat. Rev. Genet. 15, 133-141 (2014
64. Virkud Y.V., Todd R.D., Abbacchi A.M., Zhang Y., & Constantino J.N. Familial aggregation of quantitative autistic traits in multiplex versus simplex autism. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 150B, 328-334 (2009
65. Lyall K., et al. Parental social responsiveness and risk of autism spectrum disorder in offspring. JAMA Psychiatry 71, 936-942 (2014
66. Lowe J.K., Werling D.M., Constantino J.N., Cantor R.M., & Geschwind D.H. Social responsiveness, an autism endophenotype: genome-wide significant linkage to two regions on chromosome 8. Am. J. Psychiatry 172, 266-275 (2015
67. Lee S.H., et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat. Genet. 45, 984-994 (2013
68. Klei L., et al. Common genetic variants, acting additively, are a major source of risk for autism. Mol. Autism 3, 9 (2012
69. Maier R., et al. Joint analysis of psychiatric disorders increases accuracy of risk prediction for schizophrenia, bipolar disorder and major depressive disorder. Am. J. Hum. Genet. 96, 283-294 (2015
70. Anney R., et al. Individual common variants exert weak effects on the risk for autism spectrum disorders. Hum. Mol. Genet. 21, 4781-4792 (2012
71. Gratten J., Wray N.R., Keller M.C., & Visscher P.M. Large-scale genomics unveils the genetic architecture of psychiatric disorders. Nat. Neurosci. 17, 782-790 (2014
72. Geschwind D.H., & Flint J. Genetics and genomics of psychiatric disease. Science 349, 1489-1494 (2015
73. Krumm N., et al. Excess of rare, inherited truncating mutations in autism. Nat. Genet. 47, 582-588 (2015
74. Pinto D., et al. Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am. J. Hum. Genet. 94, 677-694 (2014
75. Vinkhuyzen A.A., Wray N.R., Yang J., Goddard M.E., & Visscher P.M. Estimation and partition of heritability in human populations using whole-genome analysis meth-ods. Annu. Rev. Genet. 47, 75-95 (2013
76. Sham P.C., & Purcell S.M. Statistical power and significance testing in large-scale genetic studies. Nat. Rev. Genet. 15, 335-346 (2014
77. Stessman H.A., Bernier R., & Eichler E.E. A genotype-first approach to defining the subtypes of a complex disease. Cell 156, 872-877 (2014
78. Ji J., et al. DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment and distinct facies. Eur. J. Hum. Genet. 23, 1473-1481 (2015
79. Bronicki L.M., et al. Ten new cases further delineate the syndromic intellectual disability phenotype caused by mutations in DYRK1A. Eur. J. Hum. Genet. 23, 1482-1487 (2015
80. Bernier R., et al. Disruptive CHD8 mutations define a subtype of autism early in development. Cell 158, 263-276 (2014
81. Jablensky A. Schizophrenia or schizophrenias The challenge of genetic parsing of a complex disorder. Am. J. Psychiatry 172, 105-107 (2015
82. Skafidas E., et al. Predicting the diagnosis of autism spectrum disorder using gene pathway analysis. Mol. Psychiatry 19, 504-510 (2014
83. Arnedo J., et al. Uncovering the hidden risk architecture of the schizophrenias: con-firmation in three independent genome-wide association studies. Am. J. Psychiatry 172, 139-153 (2015
84. Robinson E.B., et al. Response to Predicting the diagnosis of autism spectrum disorder using gene pathway analysis. Mol. Psychiatry 19, 859-861 (2014
85. Belgard T.G., Jankovic I., Lowe J.K., & Geschwind D.H. Population structure con-founds autism genetic classifier. Mol. Psychiatry 19, 405-407 (2014
86. Noh H.J., et al. Network topologies and convergent etiologies arising from deletions and duplications observed in individuals with autism. PLoS Genet. 9, e1003523 (2013
87. Willsey A.J., et al. Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell 155, 997-1007 (2013
88. Parikshak N.N., et al. Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell 155, 1008-1021 (2013
89. Voineagu I., et al. Transcriptomic analysis of autistic brain reveals convergent molecu-lar pathology. Nature 474, 380-384 (2011
90. Abrahams B.S., & Geschwind D.H. Advances in autism genetics: on the threshold of a new neurobiology. Nat. Rev. Genet. 9, 341-355 (2008
91. Pankevich D.E., Wizemann T.M., & Altevogt B.M. Improving the Utility and Translation of Animal Models for Nervous System Disorders: Workshop Summary (The National Academies Press, Washington D.C., 2013
92. Dolmetsch R., & Geschwind D.H. The human brain in a dish: the promise of iPSC-derived neurons. Cell 145, 831-834 (2011
93. Silverman J.L., Yang M., Lord C., & Crawley J.N. Behavioral phenotyping assays for mouse models of autism. Nat. Rev. Neurosci. 11, 490-502 (2010
94. Watson K.K., & Platt M.L. Of mice and monkeys: using nonhuman primate models to bridge mouse-and human-based investigations of autism spectrum disorders. J. Neurodev. Disord. 4, 21 (2012
95. McCammon J.M., & Sive H. Addressing the genetics of human mental health disor-ders in model organisms. Annu. Rev. Genomics Hum. Genet. 16, 173-197 (2015
96. Tian Y., et al. Alteration in basal and depolarization-induced transcriptional network in iPSC-derived neurons from Timothy syndrome. Genome Med. 6, 75 (2014
97. Fogel B.L., et al. RBFOX1 regulates both splicing and transcriptional networks in human neuronal development. Hum. Mol. Genet. 21, 4171-4186 (2012
98. Sugathan A., et al. CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors. Proc. Natl. Acad. Sci. USA 111, E4468-E4477 (2014
99. Paşca S.P., et al. Using iPSC-derived neurons to uncover cellular phenotypes associ-ated with Timothy syndrome. Nat. Med. 17, 1657-1662 (2011
100. Marchetto M.C., et al. A model for neural development and treatment of Rett syn-drome using human induced pluripotent stem cells. Cell 143, 527-539 (2010
101. Li Y., et al. Global transcriptional and translational repression in human embryonic stem cell-derived Rett syndrome neurons. Cell Stem Cell 13, 446-458 (2013
102. Shcheglovitov A., et al. SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients. Nature 503, 267-271 (2013
103. Mariani J., et al. FOXG1-dependent dysregulation of GABA-glutamate neuron dif-ferentiation in autism spectrum disorders. Cell 162, 375-390 (2015
104. Casanova M.F., et al. Minicolumnar abnormalities in autism. Acta Neuropathol. 112, 287-303 (2006
105. Stoner R., et al. Patches of disorganization in the neocortex of children with autism. N. Engl. J. Med. 370, 1209-1219 (2014
106. Redcay E., & Courchesne E. When is the brain enlarged in autism A meta-analysis of all brain size reports. Biol. Psychiatry 58, 1-9 (2005
107. Magri L., et al. Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions. Cell Stem Cell 9, 447-462 (2011
108. La Fata G., et al. FMRP regulates multipolar to bipolar transition affecting neuronal migration and cortical circuitry. Nat. Neurosci. 17, 1693-1700 (2014
109. Peñagarikano O., et al. Absence of Cntnap2 leads to epilepsy, neuronal migration abnormalities and core autism-related deficits. Cell 147, 235-246 (2011
110. Feng W., et al. The chromatin remodeler CHD7 regulates adult neurogenesis via activation of SoxC transcription factors. Cell Stem Cell 13, 62-72 (2013
111. Zhou J., et al. Tsc1-mutant neural stem and progenitor cells exhibit migration defi-cits and give rise to subependymal lesions in the lateral ventricle. Genes Dev. 25, 1595-1600 (2011
112. Sarbassov D.D., Ali S.M., & Sabatini D.M. Growing roles for the mTOR pathway. Curr. Opin. Cell Biol. 17, 596-603 (2005
113. Lipton J.O., & Sahin M. The neurology of mTOR. Neuron 84, 275-291 (2014
114. Kwon C.H., et al. Pten regulates neuronal arborization and social interaction in mice. Neuron 50, 377-388 (2006
115. Krumm N., Oroak B.J., Shendure J., & Eichler E.E. A de novo convergence of autism genetics and molecular neuroscience. Trends Neurosci. 37, 95-105 (2014
116. Hansen D.V., Rubenstein J.L., & Kriegstein A.R. Deriving excitatory neurons of the neocortex from pluripotent stem cells. Neuron 70, 645-660 (2011
117. Tiberi L., Vanderhaeghen P., & van den Ameele J. Cortical neurogenesis and mor-phogens: diversity of cues, sources and functions. Curr. Opin. Cell Biol. 24, 269-276 (2012
118. Lijam N., et al. Social interaction and sensorimotor-gating abnormalities in mice lacking Dvl1. Cell 90, 895-905 (1997
119. Sowers L.P., et al. Disruption of the noncanonical Wnt gene PRICKLE2 leads to autism-like behaviors with evidence for hippocampal synaptic dysfunction. Mol. Psychiatry 18, 1077-1089 (2013
120. Fang W.Q., et al. Overproduction of upper-layer neurons in the neocortex leads to autism-like features in mice. Cell Reports 9, 1635-1643 (2014
121. Long J.M., LaPorte P., Paylor R., & Wynshaw-Boris A. Expanded characterization of the social-interaction abnormalities in mice lacking Dvl1. Genes Brain Behav. 3, 51-62 (2004
122. Bedogni F., et al. Tbr1 regulates regional and laminar identity of postmitotic neurons in developing neocortex. Proc. Natl. Acad. Sci. USA 107, 13129-13134 (2010
123. Sakamoto I., et al. A novel b-catenin-binding protein inhibits b-catenin-dependent Tcf activation and axis formation. J. Biol. Chem. 275, 32871-32878 (2000
124. Schuettengruber B., Martinez A.M., Iovino N., & Cavalli G. Trithorax group proteins: switching genes on and keeping them active. Nat. Rev. Mol. Cell Biol. 12, 799-814 (2011
125. Nozawa R.S., et al. Human POGZ modulates dissociation of HP1-a from mitotic chromosome arms through Aurora B activation. Nat. Cell Biol. 12, 719-727 (2010
126. Chen T., & Dent S.Y. Chromatin modifiers and remodelers: regulators of cellular differentiation. Nat. Rev. Genet. 15, 93-106 (2014
127. Ronan J.L., Wu W., & Crabtree G.R. From neural development to cognition: unex-pected roles for chromatin. Nat. Rev. Genet. 14, 347-359 (2013
128. Hevner R.F., et al. Tbr1 regulates differentiation of the preplate and layer 6. Neuron 29, 353-366 (2001
129. Sierra J., Yoshida T., Joazeiro C.A., & Jones K.A. The APC tumor suppressor coun-teracts b-catenin activation and H3K4 methylation at Wnt target genes. Genes Dev. 20, 586-600 (2006
130. Stein J.L., et al. A quantitative framework to evaluate modeling of cortical develop-ment by neural stem cells. Neuron 83, 69-86 (2014
131. Miller J.A., et al. Transcriptional landscape of the prenatal human brain. Nature 508, 199-206 (2014
132. Tuoc T.C., et al. Chromatin regulation by BAF170 controls cerebral cortical size and thickness. Dev. Cell 25, 256-269 (2013
133. Cotney J., et al. The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment. Nat. Commun. 6, 6404 (2015
134. Nishiyama M., Skoultchi A.I., & Nakayama K.I. Histone H1 recruitment by CHD8 is essential for suppression of the Wnt-b-catenin signaling pathway. Mol. Cell. Biol. 32, 501-512 (2012
135. Vaags A.K., et al. Rare deletions at the neurexin 3 locus in autism spectrum disorder. Am. J. Hum. Genet. 90, 133-141 (2012
136. Gauthier J., et al. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum. Genet. 130, 563-573 (2011
137. Jamain S., et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 34, 27-29 (2003
138. Berkel S., et al. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat. Genet. 42, 489-491 (2010
139. Durand C.M., et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet. 39, 25-27 (2007
140. Piton A., et al. Analysis of the effects of rare variants on splicing identifies altera-tions in GABAA receptor genes in autism spectrum disorder individuals. Eur. J. Hum. Genet. 21, 749-756 (2013
141. Lionel A.C., et al. Rare exonic deletions implicate the synaptic organizer gephy-rin (GPHN) in risk for autism, schizophrenia and seizures. Hum. Mol. Genet. 22, 2055-2066 (2013
142. Fassio A., et al. SYN1 loss-of-function mutations in autism and partial epilepsy cause impaired synaptic function. Hum. Mol. Genet. 20, 2297-2307 (2011
143. Corradi A., et al. SYN2 is an autism predisposing gene: loss-of-function mutations alter synaptic vesicle cycling and axon outgrowth. Hum. Mol. Genet. 23, 90-103 (2014
144. Tang G., et al. Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits. Neuron 83, 1131-1143 (2014
145. Hutsler J.J., & Zhang H. Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders. Brain Res. 1309, 83-94 (2010
146. Blatt G.J., et al. Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. J. Autism Dev. Disord. 31, 537-543 (2001
147. Oblak A., Gibbs T.T., & Blatt G.J. Decreased GABAA receptors and benzodiazepine-binding sites in the anterior cingulate cortex in autism. Autism Res. 2, 205-219 (2009
148. Oblak A.L., Gibbs T.T., & Blatt G.J. Decreased GABAB receptors in the cingulate cortex and fusiform gyrus in autism. J. Neurochem. 114, 1414-1423 (2010
149. Fatemi S.H., et al. mRNA and protein levels for GABAA-a4, -a5, -b1 and GABABR1 receptors are altered in brains from subjects with autism. J. Autism Dev. Disord. 40, 743-750 (2010
150. Yip J., Soghomonian J.J., & Blatt G.J. Increased GAD67 mRNA expression in cer-ebellar interneurons in autism: implications for Purkinje cell dysfunction. J. Neurosci. Res. 86, 525-530 (2008
151. Yip J., Soghomonian J.J., & Blatt G.J. Decreased GAD65 mRNA levels in select subpopulations of neurons in the cerebellar dentate nuclei in autism: an in situ hybridization study. Autism Res. 2, 50-59 (2009
152. Yip J., Soghomonian J.J., & Blatt G.J. Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications. Acta Neuropathol. 113, 559-568 (2007
153. Fatemi S.H., et al. Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol. Psychiatry 52, 805-810 (2002
154. Südhof T.C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455, 903-911 (2008
155. Citri A., & Malenka R.C. Synaptic plasticity: multiple forms, functions and mecha-nisms. Neuropsychopharmacology 33, 18-41 (2008
156. Mayford M., Siegelbaum S.A., & Kandel E.R. Synapses and memory storage. Cold Spring Harb. Perspect. Biol. 4, a005751 (2012
157. Yizhar O., et al. Neocortical excitation-inhibition balance in information processing and social dysfunction. Nature 477, 171-178 (2011
158. Palop J.J., et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimers disease. Neuron 55, 697-711 (2007
159. Fritschy J.M. Epilepsy, E/I balance and GABAA receptor plasticity. Front. Mol. Neurosci. 1, 5 (2008
160. Kehrer C., Maziashvili N., Dugladze T., & Gloveli T. Altered excitatory-inhibitory balance in the NMDA-hypofunction model of schizophrenia. Front. Mol. Neurosci. 1, 6 (2008
161. Van De Lagemaat L.N., et al. Age-related decreased inhibitory versus excitatory gene expression in the adult autistic brain. Front. Neurosci. 8, 394 (2014
162. Rojas D.C., Singel D., Steinmetz S., Hepburn S., & Brown M.S. Decreased left perisylvian GABA concentration in children with autism and unaffected siblings. Neuroimage 86, 28-34 (2014
163. Bejjani A., et al. Elevated glutamatergic compounds in pregenual anterior cingulate in pediatric autism spectrum disorder demonstrated by 1H MRS and 1H MRSI. PLoS One 7, e38786 (2012
164. Greer P.L., & Greenberg M.E. From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function. Neuron 59, 846-860 (2008
165. Buffington S.A., Huang W., & Costa-Mattioli M. Translational control in synaptic plasticity and cognitive dysfunction. Annu. Rev. Neurosci. 37, 17-38 (2014
166. Amir R.E., et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23, 185-188 (1999
167. Splawski I., et al. CaV1.2 calcium channel dysfunction causes a multisystem disorder, including arrhythmia and autism. Cell 119, 19-31 (2004
168. Ebert D.H., & Greenberg M.E. Activity-dependent neuronal signaling and autism spectrum disorder. Nature 493, 327-337 (2013
169. Nicholls R.D., & Knepper J.L. Genome organization, function and imprinting in Prader-Willi and Angelman syndromes. Annu. Rev. Genomics Hum. Genet. 2, 153-175 (2001
170. Huang T.N., et al. Tbr1 haploinsufficiency impairs amygdalar axonal projections and results in cognitive abnormality. Nat. Neurosci. 17, 240-247 (2014
171. Chuang H.C., Huang T.N., & Hsueh Y.P. Neuronal excitation upregulates Tbr1, a high-confidence risk gene of autism, mediating Grin2b expression in the adult brain. Front. Cell. Neurosci. 8, 280 (2014
172. Flavell S.W., et al. Activity-dependent regulation of MEF2 transcription factors sup-presses excitatory synapse number. Science 311, 1008-1012 (2006
173. Chen W.G., et al. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302, 885-889 (2003
174. Zhou Z., et al. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth and spine maturation. Neuron 52, 255-269 (2006
175. Castro J., et al. Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome. Proc. Natl. Acad. Sci. USA 111, 9941-9946 (2014
176. Tropea D., et al. Partial reversal of Rett syndrome-like symptoms in MeCP2-mutant mice. Proc. Natl. Acad. Sci. USA 106, 2029-2034 (2009
177. Bozdagi O., Tavassoli T., & Buxbaum J.D. Insulin-like growth factor 1 rescues synaptic and motor deficits in a mouse model of autism and developmental delay. Mol. Autism 4, 9 (2013
178. Subramaniam S., et al. Insulin-like growth factor 1 inhibits extracellular signal-regulated kinase to promote neuronal survival via the phosphatidylinositol 3-kinase-protein kinase A-c-Raf pathway. J. Neurosci. 25, 2838-2852 (2005
179. Ehninger D., & Silva A.J. Rapamycin for treating tuberous sclerosis and autism spectrum disorders. Trends Mol. Med. 17, 78-87 (2011
180. Bassell G.J., & Warren S.T. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 60, 201-214 (2008
181. Napoli I., et al. The fragile X syndrome protein represses activity-dependent transla-tion through CYFIP1, a new 4E-BP. Cell 134, 1042-1054 (2008
182. Nishimura Y., et al. Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. Hum. Mol. Genet. 16, 1682-1698 (2007
183. Tsai P.T., et al. Autistic-like behavior and cerebellar dysfunction in Purkinje cell Tsc1-mutant mice. Nature 488, 647-651 (2012
184. Zhou J., et al. Pharmacological inhibition of mTORC1 suppresses anatomical, cellular and behavioral abnormalities in neural-specific Pten-knockout mice. J. Neurosci. 29, 1773-1783 (2009
185. Gkogkas C.G., et al. Autism-related deficits via dysregulated eIF4E-dependent trans-lational control. Nature 493, 371-377 (2013
186. Santini E., et al. Exaggerated translation causes synaptic and behavioral aberrations associated with autism. Nature 493, 411-415 (2013
187. Berg J.M., et al. JAKMIP1, a novel regulator of neuronal translation, modulates synaptic function and autistic-like behaviors in mouse. Neuron 88, 1173-1191 (2015
188. Darnell J.C., et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146, 247-261 (2011
189. Huber K.M., Gallagher S.M., Warren S.T., & Bear M.F. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc. Natl. Acad. Sci. USA 99, 7746-7750 (2002
190. Cohen S., & Greenberg M.E. Communication between the synapse and the nucleus in neuronal development, plasticity and disease. Annu. Rev. Cell Dev. Biol. 24, 183-209 (2008
191. Hua J.Y., & Smith S.J. Neural activity and the dynamics of central nervous system development. Nat. Neurosci. 7, 327-332 (2004
192. Tsai N.P., et al. Multiple autism-linked genes mediate synapse elimination via proteasomal degradation of a synaptic scaffold PSD-95. Cell 151, 1581-1594 (2012
193. Wilkerson J.R., et al. A role for dendritic mGluR5-mediated local translation of Arc (Arg 3.1) in MEF2-dependent synapse elimination. Cell Rep. 7, 1589-1600 (2014
194. Abrahams B.S., & Geschwind D.H. Connecting genes to brain in the autism spectrum disorders. Arch. Neurol. 67, 395-399 (2010
195. Yerys B.E., & Herrington J.D. Multimodal imaging in autism: an early review of comprehensive neural circuit characterization. Curr. Psychiatry Rep. 16, 496 (2014
196. Luckhardt C., Jarczok T.A., & Bender S. Elucidating the neurophysiological under-pinnings of autism spectrum disorder: new developments. J. Neural Transm. 121, 1129-1144 (2014
197. Ecker C., Bookheimer S.Y., & Murphy D.G. Neuroimaging in autism spectrum disor-der: brain structure and function across the lifespan. Lancet Neurol. 14, 1121-1134 (2015
198. Minshew N.J., & Williams D.L. The new neurobiology of autism: cortex, connectivity and neuronal organization. Arch. Neurol. 64, 945-950 (2007
199. Zikopoulos B., & Barbas H. Changes in prefrontal axons may disrupt the network in autism. J. Neurosci. 30, 14595-14609 (2010
200. McPartland J.C., Coffman M., & Pelphrey K.A. Recent advances in understanding the neural bases of autism spectrum disorder. Curr. Opin. Pediatr. 23, 628-632 (2011
201. Rudie J.D., et al. Autism-associated promoter variant in MET impacts functional and structural brain networks. Neuron 75, 904-915 (2012
202. Amaral D.G., Schumann C.M., & Nordahl C.W. Neuroanatomy of autism. Trends Neurosci. 31, 137-145 (2008
203. Vissers M.E., Cohen M.X., & Geurts H.M. Brain connectivity and high functioning autism: a promising path of research that needs refined models, methodological convergence and stronger behavioral links. Neurosci. Biobehav. Rev. 36, 604-625 (2012
204. Ellegood J., et al. Clustering autism: using neuroanatomical differences in 26 mouse models to gain insight into the heterogeneity. Mol. Psychiatry 20, 118-125 (2015
205. Kloth A.D., et al. Cerebellar associative sensory learning defects in five mouse autism models. eLife 4, e06085 (2015
206. Wang S.S., Kloth A.D., & Badura A. The cerebellum, sensitive periods and autism. Neuron 83, 518-532 (2014
207. Amaral D.G. The amygdala, social behavior and danger detection. Ann. NY Acad. Sci. 1000, 337-347 (2003
208. Baron-Cohen S., et al. The amygdala theory of autism. Neurosci. Biobehav. Rev. 24, 355-364 (2000
209. Langen M., Durston S., Kas M.J., van Engeland H., & Staal W.G. The neurobiology of repetitive behavior: and men. Neurosci. Biobehav. Rev. 35, 356-365 (2011
210. Peça J., et al. Shank3-mutant mice display autistic-like behaviors and striatal dys-function. Nature 472, 437-442 (2011
211. Rothwell P.E., et al. Autism-associated neuroligin-3 mutations commonly impair striatal circuits to boost repetitive behaviors. Cell 158, 198-212 (2014
212. Geschwind D.H., & Rakic P. Cortical evolution: judge the brain by its cover. Neuron 80, 633-647 (2013
213. Kasthuri N., et al. Saturated reconstruction of a volume of neocortex. Cell 162, 648-661 (2015
214. Zingg B., et al. Neural networks of the mouse neocortex. Cell 156, 1096-1111 (2014
215. Gunaydin L.A., et al. Natural neural projection dynamics underlying social behavior. Cell 157, 1535-1551 (2014
216. Marlin B.J., Mitre M., Damour J.A., Chao M.V., & Froemke R.C. Oxytocin enables maternal behavior by balancing cortical inhibition. Nature 520, 499-504 (2015
217. Morgan J.T., et al. Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol. Psychiatry 68, 368-376 (2010
218. Suzuki K., et al. Microglial activation in young adults with autism spectrum disorder. JAMA Psychiatry 70, 49-58 (2013
219. Tetreault N.A., et al. Microglia in the cerebral cortex in autism. J. Autism Dev. Disord. 42, 2569-2584 (2012
220. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., & Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 57, 67-81 (2005
221. Laurence J.A., & Fatemi S.H. Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects. Cerebellum 4, 206-210 (2005
222. Lopez-Hurtado E., & Prieto J. A microscopic study of language-related cortex in autism. Am. J. Biochem. Biotechnol. 4, 130-145 (2008
223. Gupta S., et al. Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism. Nat. Commun. 5, 5748 (2014
224. Paolicelli R.C., et al. Synaptic pruning by microglia is necessary for normal brain development. Science 333, 1456-1458 (2011
225. Zhan Y., et al. Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior. Nat. Neurosci. 17, 400-406 (2014
226. Chung W.S., et al. Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature 504, 394-400 (2013
227. Clarke L.E., & Barres B.A. Emerging roles of astrocytes in neural circuit development. Nat. Rev. Neurosci. 14, 311-321 (2013
228. Schafer D.P., et al. Microglia sculpt postnatal neural circuits in an activity-and complement-dependent manner. Neuron 74, 691-705 (2012
229. de Vrij F.M., et al. Rescue of behavioral phenotype and neuronal protrusion morphol-ogy in Fmr1 KO mice. Neurobiol. Dis. 31, 127-132 (2008
230. Silverman J.L., Tolu S.S., Barkan C.L., & Crawley J.N. Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. Neuropsychopharmacology 35, 976-989 (2010
231. Tian D., et al. Contribution of mGluR5 to pathophysiology in a mouse model of human chromosome 16p11.2 microdeletion. Nat. Neurosci. 18, 182-184 (2015
232. Won H., et al. Autistic-like social behavior in Shank2-mutant mice improved by restoring NMDA receptor function. Nature 486, 261-265 (2012
233. Yan Q.J., Rammal M., Tranfaglia M., & Bauchwitz R.P. Suppression of two major fragile X syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology 49, 1053-1066 (2005
234. Benson A.D., Burket J.A., & Deutsch S.I. Balb/c mice treated with d-cycloserine arouse increased social interest in conspecifics. Brain Res. Bull. 99, 95-99 (2013
235. Blundell J., et al. Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior. J. Neurosci. 30, 2115-2129 (2010
236. Burket J.A., Benson A.D., Tang A.H., & Deutsch S.I. d-cycloserine improves socia-bility in the BTBR T+ Itpr3tf/J mouse model of autism spectrum disorders with altered Ras-Raf-ERK1/2 signaling. Brain Res. Bull. 96, 62-70 (2013
237. Auerbach B.D., Osterweil E.K., & Bear M.F. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480, 63-68 (2011
238. Han S., Tai C., Jones C.J., Scheuer T., & Catterall W.A. Enhancement of inhibitory neurotransmission by GABAA receptors having a2,3-subunits ameliorates behavioral deficits in a mouse model of autism. Neuron 81, 1282-1289 (2014
239. Han S., et al. Autistic-like behaviour in Scn1a+/-mice and rescue by enhanced GABA-mediated neurotransmission. Nature 489, 385-390 (2012
240. Ehninger D., et al. Reversal of learning deficits in a Tsc2+/-mouse model of tuberous sclerosis. Nat. Med. 14, 843-848 (2008
241. Oguro-Ando A., et al. Increased CYFIP1 dosage alters cellular and dendritic morphol-ogy and dysregulates mTOR. Mol. Psychiatry 20, 1069-1078 (2015
242. Ru W., Peng Y., Zhong L., & Tang S.J. A role of the mammalian target of rapamycin (mTOR) in glutamate-induced downregulation of tuberous sclerosis complex proteins 2 (TSC2). J. Mol. Neurosci. 47, 340-345 (2012
243. Chang Q., Khare G., Dani V., Nelson S., & Jaenisch R. The disease progression of Mecp2-mutant mice is affected by the level of BDNF expression. Neuron 49, 341-348 (2006
244. Kline D.D., Ogier M., Kunze D.L., & Katz D.M. Exogenous brain-derived neuro-trophic factor rescues synaptic dysfunction in Mecp2-null mice. J. Neurosci. 30, 5303-5310 (2010
245. Mellios N., et al. b2-adrenergic receptor agonist ameliorates phenotypes and corrects microRNA-mediated IGF1 deficits in a mouse model of Rett syndrome. Proc. Natl. Acad. Sci. USA 111, 9947-9952 (2014
246. Deogracias R., et al. Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome. Proc. Natl. Acad. Sci. USA 109, 14230-14235 (2012
247. Ross H.E., & Young L.J. Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior. Front. Neuroendocrinol. 30, 534-547 (2009
248. Insel T.R. The challenge of translation in social neuroscience: a review of oxytocin, vasopressin and affiliative behavior. Neuron 65, 768-779 (2010
249. Peñagarikano O., et al. Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism. Sci. Transl. Med. 7, 271ra8 (2015
250. Sala M., et al. Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression and seizure susceptibility in oxytocin receptor-null mice: a neurobehavioral model of autism. Biol. Psychiatry 69, 875-882 (2011
251. Tyzio R., et al. Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring. Science 343, 675-679 (2014
252. Owen S.F., et al. Oxytocin enhances hippocampal spike transmission by modulating fast-spiking interneurons. Nature 500, 458-462 (2013
253. Hsiao E.Y., et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155, 1451-1463 (2013
254. Ey E., et al. Absence of deficits in social behaviors and ultrasonic vocalizations in later generations of mice lacking neuroligin 4-like. Genes Brain Behav. 11, 928-941 (2012
255. Bernardet M., & Crusio W.E. Fmr1 KO mice as a possible model of autistic features. ScientificWorldJournal 6, 1164-1176 (2006
256. Chadman K.K., et al. Minimal aberrant behavioral phenotypes of neuroligin-3R451C-knockin mice. Autism Res. 1, 147-158 (2008
257. Jacquemont S., et al. Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. Sci. Transl. Med. 3, 64ra1 (2011
258. Tachibana M., et al. Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders. J. Child Adolesc. Psychopharmacol. 23, 123-127 (2013
259. Dadds M.R., et al. Nasal oxytocin for social deficits in childhood autism: a random-ized controlled trial. J. Autism Dev. Disord. 44, 521-531 (2014
260. Guastella A.J., et al. The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial. J. Child Psychol. Psychiatry 56, 444-452 (2015
261. Jeste S.S., & Geschwind D.H. Clinical trials for neurodevelopmental disorders: at a therapeutic frontier. Sci. Transl. Med. 8, 321fs1 (2016
262. Bailey K.R., Rustay N.R., & Crawley J.N. Behavioral phenotyping of transgenic and knockout mice: practical concerns and potential pitfalls. ILAR J. 47, 124-131 (2006
263. Werling D.M., Lowe J.K., Luo R., Cantor R.M., & Geschwind D.H. Replication of linkage at chromosome 20p13 and identification of suggestive sex-differential risk loci for autism spectrum disorder. Mol. Autism 5, 13 (2014
264. Cloughesy T.F., Cavenee W.K., & Mischel P.S. Glioblastoma: from molecular pathol-ogy to targeted treatment. Annu. Rev. Pathol. 9, 1-25 (2014
265. Werker J.F., & Hensch T.K. Critical periods in speech perception: new directions. Annu. Rev. Psychol. 66, 173-196 (2015
266. Falconer D.S. The inheritance of liability to certain diseases, estimated from the incidence among relatives. Ann. Hum. Genet. 29, 51-76 (1965
267. Isshiki M., et al. Enhanced synapse remodeling as a common phenotype in mouse models of autism. Nat. Commun. 5, 4742 (2014
268. Nakatani J., et al. Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism. Cell 137, 1235-1246 (2009
269. Lee E.J., et al. Trans-synaptic zinc mobilization improves social interaction in two mouse models of autism through NMDAR activation. Nat. Commun. 6, 7168 (2015
270. Lim C.S., et al. Pharmacological rescue of Ras signaling, GluA1-dependent synap-tic plasticity and learning deficits in a fragile X model. Genes Dev. 28, 273-289 (2014
271. Gross C., et al. Selective role of the catalytic PI3K subunit p110-b in impaired higher-order cognition in fragile X syndrome. Cell Reports 11, 681-688 (2015
272. Osterweil E.K., Krueger D.D., Reinhold K., & Bear M.F. Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome. J. Neurosci. 30, 15616-15627 (2010
273. Etherton M.R., Blaiss C.A., Powell C.M., & Südhof T.C. Mouse neurexin I alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments. Proc. Natl. Acad. Sci. USA 106, 17998-18003 (2009
274. Grayton H.M., Missler M., Collier D.A., & Fernandes C. Altered social behaviors in neurexin-1a-knockout mice resemble core symptoms in neurodevelopmental disor-ders. PLoS One 8, e67114 (2013
275. Tabuchi K., et al. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318, 71-76 (2007
276. Etherton M., et al. Autism-linked neuroligin-3R451C mutation differentially alters hippocampal and cortical synaptic function. Proc. Natl. Acad. Sci. USA 108, 13764-13769 (2011
277. Baudouin S.J., et al. Shared synaptic pathophysiology in syndromic and nonsyn-dromic rodent models of autism. Science 338, 128-132 (2012
278. Jamain S., et al. Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc. Natl. Acad. Sci. USA 105, 1710-1715 (2008
279. Schmeisser M.J., et al. Autistic-like behaviors and hyperactivity in mice lacking ProSAP1 (Shank2). Nature 486, 256-260 (2012
280. Wang X., et al. Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum. Mol. Genet. 20, 3093-3108 (2011
281. Bozdagi O., et al. Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction and social communication. Mol. Autism 1, 15 (2010
282. Duffney L.J., et al. Autism-like deficits in Shank3-deficient mice are rescued by targeting actin regulators. Cell Rep. 11, 1400-1413 (2015
283. Gdalyahu A., et al. The autism-related protein contactin-associated protein-like 2 (CNTNAP2) stabilizes new spines: an in vivo mouse study. PLoS One 10, e0125633 (2015
284. Derecki N.C., et al. Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 484, 105-109 (2012
285. Lioy D.T., et al. A role for glia in the progression of Retts syndrome. Nature 475, 497-500 (2011
286. Langen M., Kas M.J., Staal W.G., van Engeland H., & Durston S. The neuro-biology of repetitive behavior: of mice. Neurosci. Biobehav. Rev. 35, 345-355 (2011
287. Lui J.H., et al. Radial glia require PDGFD-PDGFR-b signaling in human but not mouse neocortex. Nature 515, 264-268 (2014
288. Merkle F.T., & Eggan K. Modeling human disease with pluripotent stem cells: from genome association to function. Cell Stem Cell 12, 656-668 (2013
289. Griesi-Oliveira K., et al. Modeling nonsyndromic autism and the impact of TRPC6 disruption in human neurons. Mol. Psychiatry 20, 1350-1365 (2015
290. Ricciardi S., et al. CDKL5 ensures excitatory synapse stability by reinforcing NGL-1-PSD95 interaction in the postsynaptic compartment and is impaired in patient iPSC-derived neurons. Nat. Cell Biol. 14, 911-923 (2012
291. Kadoshima T., et al. Self-organization of axial polarity, inside-out layer pattern and species-specific progenitor dynamics in human ES cell-derived neocortex. Proc. Natl. Acad. Sci. USA 110, 20284-20289 (2013
292. Lepski G., et al. Delayed functional maturation of human neuronal progenitor cells in vitro. Mol. Cell. Neurosci. 47, 36-44 (2011
293. Mariani J., et al. Modeling human cortical development in vitro using induced plu-ripotent stem cells. Proc. Natl. Acad. Sci. USA 109, 12770-12775 (2012
294. Nicholas C.R., et al. Functional maturation of hPSC-derived forebrain interneurons requires an extended timeline and mimics human neural development. Cell Stem Cell 12, 573-586 (2013
295. Van De Leemput J., et al. CORTECON: a temporal transcriptome analysis of in vitro human cerebral cortex development from human embryonic stem cells. Neuron 83, 51-68 (2014
296. Ben-David E., & Shifman S. Combined analysis of exome sequencing points toward a major role for transcription regulation during brain development in autism. Mol. Psychiatry 18, 1054-1056 (2013
297. Paşca A.M., et al. Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat. Methods 12, 671-678 (2015
298. Espuny-Camacho I., et al. Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits in vivo. Neuron 77, 440-456 (2013
299. Hansen D.V., Lui J.H., Parker P.R., & Kriegstein A.R. Neurogenic radial glia in the outer subventricular zone of human neocortex. Nature 464, 554-561 (2010
300. Lancaster M.A., et al. Cerebral organoids model human brain development and microcephaly. Nature 501, 373-379 (2013